Medicamentos de actualidad = Drugs of today

• 

  Año 2017, Vol. 53, Número 11

  • MONOGRAPHS

    • Helicase–primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster.

      K. Shiraki

      • Resumen

      págs. 573-584

      

    • Cenegermin for the treatment of neurotrophic keratitis.

      M. Sacchetti, F. Bruscolini, A. Lambiase

      • Resumen

      págs. 585-596

      

    • Tisagenlecleucel, an approved anti-CD19 chimeric antigen receptor T-cell therapy for the treatment of leukemia.

      Yule Liu, X. Chen

      • Resumen

      págs. 597-608

      

    • Tivozanib: a new treatment option for renal cell carcinoma.

      Lucas Mazali Saes, F.A.L.M. Eskens

      • Resumen

      págs. 609-618

      

  • MEETING REPORTS

    • United European Gastroenterology Week (UEGW) 2017 – 25th Annual Conference (October 28-November 1, 2017 – Barcelona, Spain).

      Josep Pascual Torramadé

      • Resumen

      págs. 619-624

      

  • NEW PRODUCT INTROS

    • New product intros (acalabrutinib, elsulfavirine sodium, ferric citrate (new indication), gemigliptin/rosuvastatin sodium (new combination), influenza vaccine, quadrivalent, meropenem/vaborbactam (new combination), tivozanib, vemurafenib (new indication).

      págs. 625-627